Stock Events

Revenio 

€28.6
15
+€0.06+0.21% Friday 15:29

Statistics

Day High
29.08
Day Low
28.5
52W High
32.5
52W Low
17.51
Volume
6,439
Avg. Volume
15,495
Mkt Cap
765.99M
P/E Ratio
41.74
Dividend Yield
1.33%
Dividend
0.38

Upcoming

Dividends

1.33%Dividend Yield
10Y Growth
7.14%
5Y Growth
20.95%
3Y Growth
2.63%
1Y Growth
6.22%

Earnings

8AugConfirmed
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q1 2024
Next
0.12
0.15
0.18
0.21
Expected EPS
0.1779603
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow REG1V.HE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, rest of Europe, North America, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; and iCare TONOVET an IOP measuring on animal patients by general veterinary practitioners, veterinary ophthalmologists, and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON AF, a device with confocal retinal imaging; and DRSplus, a device for pupil imaging; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. In addition, the company offers Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.
Show more...
CEO
Mr. Jouni Toijala B.Sc., M.B.A.
Employees
219
Country
FI
ISIN
FI0009010912
WKN
000805985

Listings